165 related articles for article (PubMed ID: 21904909)
1. Distinct functional and conformational states of the human lymphoid tyrosine phosphatase catalytic domain can be targeted by choice of the inhibitor chemotype.
Vidović D; Xie Y; Rinderspacher A; Deng SX; Landry DW; Chung C; Smith DH; Tautz L; Schürer SC
J Comput Aided Mol Des; 2011 Sep; 25(9):873-83. PubMed ID: 21904909
[TBL] [Abstract][Full Text] [Related]
2. Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.
Li K; Hou X; Li R; Bi W; Yang F; Chen X; Xiao P; Liu T; Lu T; Zhou Y; Tian Z; Shen Y; Zhang Y; Wang J; Fang H; Sun J; Yu X
J Biol Chem; 2019 May; 294(21):8653-8663. PubMed ID: 30979725
[TBL] [Abstract][Full Text] [Related]
3. Covalent inhibition of the lymphoid tyrosine phosphatase.
Ahmed VF; Bottini N; Barrios AM
ChemMedChem; 2014 Feb; 9(2):296-9. PubMed ID: 24403103
[TBL] [Abstract][Full Text] [Related]
4. Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.
Du J; Qiao Y; Sun L; Wang X
Curr Drug Targets; 2014 Mar; 15(3):335-46. PubMed ID: 24188455
[TBL] [Abstract][Full Text] [Related]
5. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
Yu X; Sun JP; He Y; Guo X; Liu S; Zhou B; Hudmon A; Zhang ZY
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19767-72. PubMed ID: 18056643
[TBL] [Abstract][Full Text] [Related]
6. In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation.
Wu S; Bottini M; Rickert RC; Mustelin T; Tautz L
ChemMedChem; 2009 Mar; 4(3):440-4. PubMed ID: 19177473
[TBL] [Abstract][Full Text] [Related]
7. Target-specific control of lymphoid-specific protein tyrosine phosphatase (Lyp) activity.
Walton ZE; Bishop AC
Bioorg Med Chem; 2010 Jul; 18(14):4884-91. PubMed ID: 20594861
[TBL] [Abstract][Full Text] [Related]
8. Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.
Karver MR; Krishnamurthy D; Bottini N; Barrios AM
J Inorg Biochem; 2010 Mar; 104(3):268-73. PubMed ID: 20083307
[TBL] [Abstract][Full Text] [Related]
9. Regulation of lymphoid tyrosine phosphatase activity: inhibition of the catalytic domain by the proximal interdomain.
Liu Y; Stanford SM; Jog SP; Fiorillo E; Orrú V; Comai L; Bottini N
Biochemistry; 2009 Aug; 48(31):7525-32. PubMed ID: 19586056
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells.
Stanford SM; Krishnamurthy D; Falk MD; Messina R; Debnath B; Li S; Liu T; Kazemi R; Dahl R; He Y; Yu X; Chan AC; Zhang ZY; Barrios AM; Woods VL; Neamati N; Bottini N
J Med Chem; 2011 Mar; 54(6):1640-54. PubMed ID: 21341673
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of imidazolidine-2,4-dione and 2-thioxothiazolidin-4-one derivatives as lymphoid-specific tyrosine phosphatase inhibitors.
Liang X; Fu H; Xiao P; Fang H; Hou X
Bioorg Chem; 2020 Oct; 103():104124. PubMed ID: 32768742
[TBL] [Abstract][Full Text] [Related]
12. SHP family protein tyrosine phosphatases adopt canonical active-site conformations in the apo and phosphate-bound states.
Alicea-Velazquez NL; Boggon TJ
Protein Pept Lett; 2013 Sep; 20(9):1039-48. PubMed ID: 23514039
[TBL] [Abstract][Full Text] [Related]
13. Fast identification of novel lymphoid tyrosine phosphatase inhibitors using target-ligand interaction-based virtual screening.
Hou X; Li R; Li K; Yu X; Sun JP; Fang H
J Med Chem; 2014 Nov; 57(22):9309-22. PubMed ID: 25372368
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and functional studies of lymphoid-specific tyrosine phosphatase (Lyp) variants S201F and R266W.
Liu J; Chen M; Li R; Yang F; Shi X; Zhu L; Wang HM; Yao W; Liu Q; Meng FG; Sun JP; Pang Q; Yu X
PLoS One; 2012; 7(8):e43631. PubMed ID: 22952725
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acids.
Vang T; Xie Y; Liu WH; Vidović D; Liu Y; Wu S; Smith DH; Rinderspacher A; Chung C; Gong G; Mustelin T; Landry DW; Rickert RC; Schürer SC; Deng SX; Tautz L
J Med Chem; 2011 Jan; 54(2):562-71. PubMed ID: 21190368
[TBL] [Abstract][Full Text] [Related]
16. Thiuram disulfides as pseudo-irreversible inhibitors of lymphoid tyrosine phosphatase.
Kulkarni RA; Stanford SM; Vellore NA; Krishnamurthy D; Bliss MR; Baron R; Bottini N; Barrios AM
ChemMedChem; 2013 Sep; 8(9):1561-8. PubMed ID: 23873737
[TBL] [Abstract][Full Text] [Related]
17. Small molecule receptor protein tyrosine phosphatase γ (RPTPγ) ligands that inhibit phosphatase activity via perturbation of the tryptophan-proline-aspartate (WPD) loop.
Sheriff S; Beno BR; Zhai W; Kostich WA; McDonnell PA; Kish K; Goldfarb V; Gao M; Kiefer SE; Yanchunas J; Huang Y; Shi S; Zhu S; Dzierba C; Bronson J; Macor JE; Appiah KK; Westphal RS; O'Connell J; Gerritz SW
J Med Chem; 2011 Oct; 54(19):6548-62. PubMed ID: 21882820
[TBL] [Abstract][Full Text] [Related]
18. A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases.
He Y; Liu S; Menon A; Stanford S; Oppong E; Gunawan AM; Wu L; Wu DJ; Barrios AM; Bottini N; Cato AC; Zhang ZY
J Med Chem; 2013 Jun; 56(12):4990-5008. PubMed ID: 23713581
[TBL] [Abstract][Full Text] [Related]
19. Oxidative inactivation of the lymphoid tyrosine phosphatase mediated by both general and active site directed NO donors.
Karver CE; Ahmed VF; Barrios AM
Bioorg Med Chem Lett; 2011 Jan; 21(1):285-7. PubMed ID: 21129966
[TBL] [Abstract][Full Text] [Related]
20. Protein Flexibility in Docking-Based Virtual Screening: Discovery of Novel Lymphoid-Specific Tyrosine Phosphatase Inhibitors Using Multiple Crystal Structures.
Hou X; Li K; Yu X; Sun JP; Fang H
J Chem Inf Model; 2015 Sep; 55(9):1973-83. PubMed ID: 26360643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
